once they get above 50%... and control of the board - Iberdola has said they intend to exert pressure to delist the company from ASX... much less scrutiny and less focus of "benefit for all shareholders" - if TCI went with their vote (from their remaining 13% shareholding you would assume maintaining board role) we would not have a choice in the matter... outvoiced.
Agree that we could have a real stalemate here if UAC hold onto their position ... will require a fair chunk of the free standing shares to get to 50%... Vinva has a 5% stake still... and the board and their relevant associated holdings + performance rights which are expected to be issued will make another few percent - but I still feel I will be surprised if either party races towards 50%... let alone gets above 50%.
UAC have gone unconditional though - so it could just try and increase its stake to get a seat on the board and work forward with IFN... whereas Iberdola is majority holder or not at all. I still prefer option number 3.
Such a great company and we have seen / discussed many of the opportunities they have available to them here on the forum... just wish they had of come to us for a CR to get balance sheet in order for growth (increase available leverage) before having approached Iberdola and appearing (in hindsight) as having a pipeline, with no scope to develop due to capital restraints. Would have participated 200%.
- Forums
- ASX - By Stock
- IFN
- Ann: Second Supplementary Target's Statement to UAC Offer
IFN
infragreen group limited - 25 june 2025 11:00 am aest ##
Add to My Watchlist
2.68%
!
$1.15

Ann: Second Supplementary Target's Statement to UAC Offer, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.15 |
Change
0.030(2.68%) |
Mkt cap ! $155.4M |
Open | High | Low | Value | Volume |
$1.16 | $1.21 | $1.09 | $798.1K | 690.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1530 | $1.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.15 | 56379 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1530 | 1.130 |
1 | 40000 | 1.120 |
1 | 2000 | 1.110 |
1 | 10888 | 1.100 |
1 | 733 | 1.090 |
Price($) | Vol. | No. |
---|---|---|
1.150 | 56379 | 2 |
1.190 | 4706 | 1 |
1.200 | 15000 | 1 |
1.210 | 21405 | 1 |
0.000 | 0 | 0 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
IFN (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online